Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Haavik

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
Archives of General Psychiatry|October 6, 2010
Attention-deficit/hyperactivity disorder symptoms in offspring of mothers with impaired serotonin productionAnne Halmøy, Stefan Johansson, Ingeborg Winge, et al.
The FEBS Journal|March 22, 2008
Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholaminesJoachim Scholz, Karen Toska, Alexander Luborzewski, et al.
Journal of Neurochemistry|November 8, 2002
Regulation of tyrosine hydroxylase by stress-activated protein kinasesKaren Toska, Rune Kleppe, Christopher G Armstrong, et al.
Amino Acids|January 31, 2016
Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteinsSadaf Ghorbani, Agnete Fossbakk, Ana Jorge-Finnigan, et al.
Journal of Affective Disorders|February 1, 2011
Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNTMichael Berk, Stefan Johansson, Naomi R Wray, et al.
Journal of Affective Disorders|October 1, 2010
No association between the serotonin transporter gene polymorphism 5-HTTLPR and cyclothymic temperament as measured by TEMPS-AElisabeth T Landaas, Stefan Johansson, Anne Halmøy, et al.
Molecular Psychiatry|October 20, 2019
Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatmentTor-Arne Hegvik, Kai Waløen, Sunil K Pandey, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidityMats Fredriksen, Alv A Dahl, Egil W Martinsen, et al.
Attention Deficit and Hyperactivity Disorders|March 31, 2019
Effect of disease-associated SLC9A9 mutations on protein-protein interaction networks: implications for molecular mechanisms for ADHD and autismYanli Zhang-James, Marc Vaudel, Olav Mjaavatten, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|December 20, 2020
Sex differences in parent-offspring recurrence of attention-deficit/hyperactivity disorderBerit S Solberg, Tor-Arne Hegvik, Anne Halmøy, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Archives of General Psychiatry|October 6, 2010
Attention-deficit/hyperactivity disorder symptoms in offspring of mothers with impaired serotonin productionAnne Halmøy, Stefan Johansson, Ingeborg Winge, et al.
The FEBS Journal|March 22, 2008
Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholaminesJoachim Scholz, Karen Toska, Alexander Luborzewski, et al.
Journal of Neurochemistry|November 8, 2002
Regulation of tyrosine hydroxylase by stress-activated protein kinasesKaren Toska, Rune Kleppe, Christopher G Armstrong, et al.
Amino Acids|January 31, 2016
Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteinsSadaf Ghorbani, Agnete Fossbakk, Ana Jorge-Finnigan, et al.
Journal of Affective Disorders|February 1, 2011
Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNTMichael Berk, Stefan Johansson, Naomi R Wray, et al.
Journal of Affective Disorders|October 1, 2010
No association between the serotonin transporter gene polymorphism 5-HTTLPR and cyclothymic temperament as measured by TEMPS-AElisabeth T Landaas, Stefan Johansson, Anne Halmøy, et al.
Molecular Psychiatry|October 20, 2019
Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatmentTor-Arne Hegvik, Kai Waløen, Sunil K Pandey, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidityMats Fredriksen, Alv A Dahl, Egil W Martinsen, et al.
Attention Deficit and Hyperactivity Disorders|March 31, 2019
Effect of disease-associated SLC9A9 mutations on protein-protein interaction networks: implications for molecular mechanisms for ADHD and autismYanli Zhang-James, Marc Vaudel, Olav Mjaavatten, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|December 20, 2020
Sex differences in parent-offspring recurrence of attention-deficit/hyperactivity disorderBerit S Solberg, Tor-Arne Hegvik, Anne Halmøy, et al.
Pageof 23